Literature DB >> 20685997

Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.

Jason Miller1, Montserrat Arrasate, Benjamin A Shaby, Siddhartha Mitra, Eliezer Masliah, Steven Finkbeiner.   

Abstract

An expanded polyglutamine (polyQ) stretch in the protein huntingtin (htt) induces self-aggregation into inclusion bodies (IBs) and causes Huntington's disease (HD). Defining precise relationships between early observable variables and neuronal death at the molecular and cellular levels should improve our understanding of HD pathogenesis. Here, we used an automated microscope that tracks thousands of neurons individually over their entire lifetime to quantify interconnected relationships between early variables, such as htt levels, polyQ length, and IB formation, and neuronal death in a primary striatal model of HD. The resulting model revealed that mutant htt increases the risk of death by tonically interfering with homeostatic coping mechanisms rather than producing accumulated damage to the neuron, htt toxicity is saturable, the rate-limiting steps for inclusion body formation and death can be traced to different conformational changes in monomeric htt, and IB formation reduces the impact of the starting levels of htt of a neuron on its risk of death. Finally, the model that emerges from our quantitative measurements places critical limits on the potential mechanisms by which mutant htt might induce neurodegeneration, which should help direct future research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685997      PMCID: PMC3078518          DOI: 10.1523/JNEUROSCI.0146-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  56 in total

1.  Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

Authors:  A Yamamoto; J J Lucas; R Hen
Journal:  Cell       Date:  2000-03-31       Impact factor: 41.582

2.  Biologically active molecules that reduce polyglutamine aggregation and toxicity.

Authors:  Urvee A Desai; Judit Pallos; Aye Aye K Ma; Brent R Stockwell; Leslie Michels Thompson; J Lawrence Marsh; Marc I Diamond
Journal:  Hum Mol Genet       Date:  2006-05-23       Impact factor: 6.150

3.  RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.

Authors:  Scott Q Harper; Patrick D Staber; Xiaohua He; Steven L Eliason; Inês H Martins; Qinwen Mao; Linda Yang; Robert M Kotin; Henry L Paulson; Beverly L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-05       Impact factor: 11.205

4.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease.

Authors:  Caroline L Benn; Christian Landles; He Li; Andrew D Strand; Ben Woodman; Kirupa Sathasivam; Shi-Hua Li; Shabnam Ghazi-Noori; Emma Hockly; Syed M N N Faruque; Jang-Ho J Cha; Paul T Sharpe; James M Olson; Xiao-Jiang Li; Gillian P Bates
Journal:  Hum Mol Genet       Date:  2005-09-23       Impact factor: 6.150

6.  Heterogeneous cellular environments modulate one-hit neuronal death kinetics.

Authors:  Geoff Clarke; Charles J Lumsden
Journal:  Brain Res Bull       Date:  2005-02-15       Impact factor: 4.077

Review 7.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Authors:  Charles G Glabe
Journal:  Neurobiol Aging       Date:  2006-02-14       Impact factor: 4.673

8.  In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes.

Authors:  M Dragunow; R L Faull; P Lawlor; E J Beilharz; K Singleton; E B Walker; E Mee
Journal:  Neuroreport       Date:  1995-05-09       Impact factor: 1.837

9.  Progressive disruption of cellular protein folding in models of polyglutamine diseases.

Authors:  Tali Gidalevitz; Anat Ben-Zvi; Kim H Ho; Heather R Brignull; Richard I Morimoto
Journal:  Science       Date:  2006-02-09       Impact factor: 63.714

10.  Does the effect of PM10 on mortality depend on PM nickel and vanadium content? A reanalysis of the NMMAPS data.

Authors:  Francesca Dominici; Roger D Peng; Keita Ebisu; Scott L Zeger; Jonathan M Samet; Michelle L Bell
Journal:  Environ Health Perspect       Date:  2007-12       Impact factor: 9.031

View more
  73 in total

1.  Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.

Authors:  Miriam A Hickey; Chunni Zhu; Vera Medvedeva; Nicholas R Franich; Michael S Levine; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2011-10-20       Impact factor: 4.314

2.  Bringing SOD1 into the fold.

Authors:  Sami Barmada; Steven Finkbeiner
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

Review 3.  Cell death assays for neurodegenerative disease drug discovery.

Authors:  Jeremy W Linsley; Terry Reisine; Steven Finkbeiner
Journal:  Expert Opin Drug Discov       Date:  2019-06-10       Impact factor: 6.098

Review 4.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

5.  BDNF may play a differential role in the protective effect of the mGluR2/3 agonist LY379268 on striatal projection neurons in R6/2 Huntington's disease mice.

Authors:  A Reiner; H B Wang; N Del Mar; K Sakata; W Yoo; Y P Deng
Journal:  Brain Res       Date:  2012-07-20       Impact factor: 3.252

6.  Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.

Authors:  Gaia Skibinski; Ken Nakamura; Mark R Cookson; Steven Finkbeiner
Journal:  J Neurosci       Date:  2014-01-08       Impact factor: 6.167

7.  Serine 421 regulates mutant huntingtin toxicity and clearance in mice.

Authors:  Ian H Kratter; Hengameh Zahed; Alice Lau; Andrey S Tsvetkov; Aaron C Daub; Kurt F Weiberth; Xiaofeng Gu; Frédéric Saudou; Sandrine Humbert; X William Yang; Alex Osmand; Joan S Steffan; Eliezer Masliah; Steven Finkbeiner
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

Review 8.  Modeling Huntington's disease with induced pluripotent stem cells.

Authors:  Julia A Kaye; Steven Finkbeiner
Journal:  Mol Cell Neurosci       Date:  2013-02-28       Impact factor: 4.314

9.  Heat shock promotes inclusion body formation of mutant huntingtin (mHtt) and alleviates mHtt-induced transcription factor dysfunction.

Authors:  Justin Y Chen; Miloni Parekh; Hadear Seliman; Dariya Bakshinskaya; Wei Dai; Kelvin Kwan; Kuang Yu Chen; Alice Y C Liu
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

Review 10.  Sorting out the trash: the spatial nature of eukaryotic protein quality control.

Authors:  Emily Mitchell Sontag; Willianne I M Vonk; Judith Frydman
Journal:  Curr Opin Cell Biol       Date:  2014-01-23       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.